Literature DB >> 6111322

Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis.

J Tenenbaum, O Muniz, H R Schumacher, A E Good, D S Howell.   

Abstract

One abnormality in calcium pyrophosphate deposition disease (CPDD) which fosters consistently high synovial fluid pyrophosphate ion (PPi) and large accumulations of calcium pyrophosphate dihydrate crystals (Ca pyrophosphate) might be an aberration in chondrocytes involving elaboration of PPi and failure of its hydrolysis within cartilage matrix. Exploration of this hypothesis required further information on the phosphohydrolases in relevant human articular cartilages. Triton X-100 extracts of whole homogenized cartilage from 18 patients with primary osteoarthritis (OA), 10 patients with CPDD and secondary OA, as well as 6 "normal" subjects were partially purified by DE-52 chromatography and eluates studied for phosphohydrolase activity in a variety of substrates, inhibitors, and environmental conditions. Almost all the protein as well as crude alkaline phosphatase and pyrophosphatase activities were clustered in peaks designated I and II. Findings in CPDD cartilage not observed in OA controls were: 1) consistent alkaline phosphatase activity in the void volume of DE-52 columns, 2) high levels of 5'nucleotidase activity, 3) abundant generation of PPi by CPDD cartilage during in vitro incubation of cartilage extract fractions with ATP. This enzymatic behavior is likely to bear a regulatory relationship to PPi production by chondrocytes in CPDD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111322     DOI: 10.1002/art.1780240307

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  Matrix vesicles and calcification.

Authors:  H Clarke Anderson
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

2.  Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels.

Authors:  G K Hunter; M D Grynpas; P T Cheng; K P Pritzker
Journal:  Calcif Tissue Int       Date:  1987-09       Impact factor: 4.333

Review 3.  Regulation of bone and cartilage by adenosine signaling.

Authors:  Lauren C Strazzulla; Bruce N Cronstein
Journal:  Purinergic Signal       Date:  2016-07-29       Impact factor: 3.765

4.  Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.

Authors:  L M Ryan; D J McCarty
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

5.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 6.  Crystals, joints, and consternation.

Authors:  D McCarty
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

Review 7.  Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.

Authors:  A Caswell; D F Guilland-Cumming; P R Hearn; M K McGuire; R G Russell
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

8.  Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes.

Authors:  M Lotz; F Rosen; G McCabe; J Quach; F Blanco; J Dudler; J Solan; J Goding; J E Seegmiller; R Terkeltaub
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

9.  The deposition of calcium pyrophosphate and phosphate by matrix vesicles isolated from fetal bovine epiphyseal cartilage.

Authors:  H H Hsu; H C Anderson
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

10.  Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.

Authors:  R Huang; M Rosenbach; R Vaughn; D Provvedini; N Rebbe; S Hickman; J Goding; R Terkeltaub
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.